RXi’s Therapeutic Platform (NASDAQ:RXII)
Source: http://feedproxy.google.com/~r/FavStocks/~3/rzSww6a7yKE/Posted on Wednesday, November 4th, 2009 | In Biotech, Investing Lessons, Stocks to Watch
RXi Pharmaceuticals Corporation (NASDAQ:RXII) announced that their Vice President of Technology Development, Dmitry Samarsky will be presenting their new RNAi technology development at the Discovery on Target scientific conference in Boston on November 4, 2009.
RXi Pharmaceuticals also announced that the presentation of the development will not be webcasted. RXi Pharmaceuticals is a leading discovery stage biopharmaceutical company that looks after the development and commercialization of proprietary therapeutics based on RNAi technology for the treatment of human diseases.
Currently, RXi Pharmaceuticals has a comprehensive therapeutic platform that includes both RNAi compounds and delivery methods. The Company uses its own version of RNAi compounds which provides an advanced alternative to conventional small interfering RNAs (siRNAs) and defines the next generation of RNAs. RXi’s RNAi compound (rxRNA) is specially designed for therapeutic use and contains many of the properties needed to move RNAi based drug into the clinic. RXi Pharmaceuticals have announced that at the presentation they will announce their new therapeutic platform which includes the next generation of rxRNA compounds and advanced delivery approaches for the treatment of various human diseases.
Last 5 posts by Jyotsna Ramani
- ARCA Submits New SPA (NASDAQ:ABIO) - December 23rd, 2009
- ARCA Submits New SPA (NASDAQ:ABIO) - December 23rd, 2009
- Xcorporeal Signs Purchase Agreement (OTC:XCRP) - December 23rd, 2009
- Xcorporeal Signs Purchase Agreement (OTC:XCRP) - December 23rd, 2009
- Arrowhead Raises New Funds (NASDAQ:ARWR) - December 23rd, 2009
 About Jyotsna Ramani (http://www.favstocks.com)
Joyotsna has completed Post Graduation in Tourism from College of Vocational Studies apart from a full time MBA degree in Finance. She has worked with several reputed companies including IBM. Currently, she is a SAHM, earning a living off trading in the stock market and forex. |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.